Heart & Lung: The Journal of Acute and Critical Care
Volume 39, Issue 1 , Pages 12-20 , January 2010

Patient perception of symptoms and quality of life following ablation in patients with supraventricular tachycardia

  • Kathryn A. Wood, RN, PhD

      Affiliations

    • Duke University School of Nursing, Durham, NC, USA
    • Corresponding Author InformationCorresponding author: Kathryn A. Wood, RN, PhD, Duke University School of Nursing, 307 Trent Drive, Room 3065, DUMC Box 3322, Durham, NC 27710
    • ,
  • Anita L. Stewart, PhD

      Affiliations

    • Institute For Health & Aging, University of California, San Francisco
    • ,
  • Barbara J. Drew, RN, PhD, FAAN

      Affiliations

    • Department of Physiologic Nursing, School of Nursing, University of California, San Francisco
    • ,
  • Melvin M. Scheinman, MD, FACC

      Affiliations

    • Division of Cardiology, Electrophysiology Section, School of Medicine, University of California, San Francisco, CA, USA
    • ,
  • Erika S. Froëlicher, RN, PhD, FAAN

      Affiliations

    • Department of Physiologic Nursing, School of Nursing, University of California, San Francisco

References 

  1. Cohn J. Efficacy and safety in clinical trials in cardiovascular disease. J Am Coll Cardiol. 2006;48:430–433
  2. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, et al. ACC/AHA/ESC guidelines for management of supraventricular arrhythmias: executive summary. Circulation. 2003;108:1871–1909
  3. Morady F. Catheter ablation of supraventricular arrhythmias: state of the art. Pacing Clin Electrophysiol. 2004;27:125–142
  4. Josephson ME, Wellens H. Differential diagnosis of supraventricular tachycardia. Cardiol Clin. 1990;8:411–442
  5. Wood K. Mechanisms and clinical manifestations of supraventricular tachycardias. Prog Cardiovasc Nurs. 1995;10:3–14
  6. Wood KA, Wiener CL, Kayser-Jones J. Supraventricular tachycardia and the struggle to be believed. Eur J Cardiovasc Nurs. 2007;6:293–302
  7. Walfridsson U, Walfridsson H. The impact of supraventricular tachycardias on driving ability in patients referred for radiofrequency catheter ablation. Pacing Clin Electrophysiol. 2005;28:191–195
  8. Wood KA, Drew BJ, Scheinman MM. Frequency of disabling symptoms in supraventricular tachycardia. Am J Cardiol. 1997;79:145–149
  9. Dhala A, Bemner S, Black Z, et al. Impairment of driving abilities in patients with supraventricular tachycardias. Am J Cardiol. 1995;75:516–518
  10. Bubien RS, Knotts-Dolson SM, Plumb VJ, Kay GN. The effect of radiofrequency QOL in SVT 18 catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation. 1996;96:1585–1591
  11. Lau CP, Tai YT, Lee PWH. The effects of radiofrequency ablation versus medical therapy on the quality of life and exercise capacity in patients with accessory pathway-mediated supraventricular tachycardia: A treatment comparison study. Pacing Clin Electrophysiol. 1995;18(Part I):424–432
  12. Goldberg AS, Bathina MN, Mickelsen S, Nawman R, West G, Kusumoto FM. Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy). Am J Cardiol. 2002;89:1120–1123
  13. Cheng CH, Sanders GD, Hlatky MA, et al. Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia. Ann Intern Med. 2000;133:864–876
  14. Bathina MN, Mickelsen S, Brooks C, Jaramillo J, Hepton T, Kusumoto FM. Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs. Am J Cardiol. 1998;82:589–593
  15. Larson MS, McDonald K, Young C, Sung R, Hlatky MA. Quality of life before and after radiofrequency catheter ablation in patients with drug refractory atrioventricular nodal reentrant tachycardia. Am J Cardiol. 1999;84:471–473A9
  16. Lessmeier TJ, Gamperling D, Johnson-Liddon V, Fromm BS, Steinman RT, Meissner MD, et al. Unrecognized paroxysmal supraventricular tachycardia. Potential for misdiagnosis as panic disorder. Arch Intern Med. 1997;157:537–543
  17. Dagres N, Clague JR, Breithardt G, Borggrefe M. Significant gender-related differences in radiofrequency catheter ablation therapy. J Am Coll Cardiol. 2003;42:1103–1107
  18. Wood KA, Stewart AL, Drew BJ, Scheinman MM, Froelicher ES. Development and initial psychometric evaluation of the Patient Perspective of Arrhythmia questionnaire. Res Nurs Health. 2009;in press
  19. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center; 1993;
  20. In:  Stewart AL,  Hays RD,  Ware JE editor. The MOS short-form general health survey: reliability and validity in a patient population. 26:Med Care; 1988;p. 724–735
  21. Stewart AL, Ware JE. Measuring functioning and well-being: The medical outcomes study approach. Durham, NC: Duke University Press; 1992;
  22. Gursoy S, Steurer G, Brugada J, Andries E, Brugada P. Brief report: the hemodynamic mechanism of pounding in the neck in atrioventricular nodal reentrant tachycardia. N Eng J Med. 1992;327:772–774
  23. Chen W, Woods SL, Wilkie DJ, Puntillo KA. Gender differences in symptom experiences of patients with acute coronary syndromes. J Pain Symptom Manage. 2005;30:553–562
  24. Beery TA. Gender bias in the diagnosis and treatment of coronary artery disease. Heart Lung. 1995;24:427–435

PII: S0147-9563(09)00093-4

doi: 10.1016/j.hrtlng.2009.04.001

Heart & Lung: The Journal of Acute and Critical Care
Volume 39, Issue 1 , Pages 12-20 , January 2010

Article Tools

* Image Usage & Resolution